Siemens Fonds Invest GmbH boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 2,320.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,549 shares of the company's stock after purchasing an additional 60,923 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Cardinal Health were worth $7,516,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of CAH. Norges Bank purchased a new stake in Cardinal Health during the fourth quarter worth $246,748,000. Marshall Wace LLP boosted its position in Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after purchasing an additional 1,913,892 shares in the last quarter. Castlekeep Investment Advisors LLC purchased a new stake in Cardinal Health during the fourth quarter worth $141,963,000. Junto Capital Management LP acquired a new position in shares of Cardinal Health in the fourth quarter worth $92,811,000. Finally, Woodline Partners LP acquired a new position in shares of Cardinal Health in the fourth quarter worth $87,144,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms recently weighed in on CAH. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Citigroup restated a "neutral" rating on shares of Cardinal Health in a research note on Thursday, May 1st. UBS Group upped their price target on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Finally, Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average target price of $146.43.
Get Our Latest Analysis on Cardinal Health
Cardinal Health Stock Up 0.3%
NYSE:CAH traded up $0.47 during trading hours on Friday, reaching $154.46. 2,759,499 shares of the stock were exchanged, compared to its average volume of 2,229,497. The firm has a 50 day simple moving average of $141.70 and a 200-day simple moving average of $130.26. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $156.44. The stock has a market capitalization of $36.87 billion, a P/E ratio of 28.82, a P/E/G ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. The business had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The business's revenue was up .0% on a year-over-year basis. During the same quarter last year, the business posted $2.08 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.5107 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.32%. Cardinal Health's dividend payout ratio (DPR) is 31.83%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.